Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",9015,102,1.40 [1.00-1.94],0.0487787581323412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,9115,106,2.07 [1.11-3.88],0.0230004376771763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,7849,98,1.78 [1.07-2.97],0.0275743718461111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,9153,102,1.65 [1.08-2.52],0.0196616241769205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,7849,98,1.91 [1.22-3.00],0.005006301304188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,8080,98,1.79 [1.05-3.05],0.0326433320211749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,7921,97,0.75 [0.57-1.00],0.0467594629004856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,7921,97,1.66 [1.01-2.75],0.0457476977516704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,8064,99,0.50 [0.26-0.95],0.0347821936467386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,8084,99,0.74 [0.56-0.98],0.0340297038676679
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,7921,97,0.73 [0.56-0.94],0.015408762587732
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFM,Afamin,8084,99,2.88 [1.07-7.73],0.0360396528236655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,9284,105,1.66 [1.18-2.35],0.0037488040175902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,9188,103,0.72 [0.55-0.93],0.0125772324013638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,7888,96,1.92 [1.11-3.34],0.0204239093760657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,8945,100,0.72 [0.52-0.99],0.046325144564729
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",9153,102,1.31 [1.11-1.56],0.001862810868088
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,8968,102,0.70 [0.50-0.98],0.0369925666650775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,9268,104,1.73 [1.12-2.69],0.0141099592976203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,9157,106,0.77 [0.61-0.97],0.0253829551601511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,9242,105,0.75 [0.58-0.96],0.0213103221842896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",9238,106,0.83 [0.71-0.96],0.014105016707534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,8987,101,1.51 [1.11-2.04],0.0079025738548713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,8968,102,0.79 [0.64-0.98],0.0340381567437695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,8052,99,1.48 [1.04-2.11],0.0290016484831381
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,8084,99,1.50 [1.05-2.13],0.0243912497456946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,7791,95,1.36 [1.03-1.80],0.0312075826548497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,9300,104,0.59 [0.37-0.93],0.0238755459871394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,8987,101,0.77 [0.59-1.00],0.0477357507744608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,9229,104,0.54 [0.35-0.83],0.0043998601235269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,9111,103,0.85 [0.72-1.00],0.0498575987019022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,9300,104,0.82 [0.67-0.99],0.0444254833884164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,9238,106,1.47 [1.14-1.91],0.0035853520080764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,9220,106,1.30 [1.07-1.59],0.0099271256194024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,7799,96,1.82 [1.24-2.66],0.0020550562872576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,9150,106,1.75 [1.22-2.51],0.0022818951024612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,9201,105,0.62 [0.42-0.92],0.0161376424974727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,8033,98,1.56 [1.04-2.35],0.0322907601573488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,9229,104,0.80 [0.65-0.99],0.0417857608615735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,8060,98,1.93 [1.01-3.71],0.0480529481654335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,9263,106,2.31 [1.58-3.37],1.5163248306950183e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,9188,103,1.76 [1.07-2.89],0.0246832964314725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,8987,101,0.59 [0.39-0.90],0.0141669879333806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,7921,97,2.39 [1.29-4.45],0.0059329340738987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,8968,102,0.73 [0.54-0.97],0.033022507455556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,8968,102,0.75 [0.56-0.99],0.0449954015547422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,8029,98,0.73 [0.56-0.96],0.0224550334681777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,7594,89,2.73 [1.14-6.55],0.024135913690095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,7852,92,1.50 [1.11-2.03],0.0078769600562198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,9188,103,2.70 [1.94-3.76],4.2324461517936835e-09
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,7935,94,1.43 [1.02-2.01],0.03668290563237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,7852,92,1.35 [1.00-1.83],0.0488423342669443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,7884,96,2.31 [1.08-4.95],0.0313682075316235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,9168,106,0.59 [0.37-0.95],0.0312197608403186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,8060,98,2.38 [1.37-4.12],0.0019844689348065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,9199,105,0.48 [0.24-0.98],0.0449593780934321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,7852,92,1.17 [1.00-1.37],0.0466800774793507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,7888,96,0.75 [0.58-0.96],0.0239366412376562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,9300,104,1.58 [1.01-2.48],0.0466715929693467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,8993,99,0.77 [0.61-0.96],0.0203040508223943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,9085,102,1.65 [1.05-2.59],0.0296967766983916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,9129,106,1.57 [1.08-2.29],0.017962024410719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,9238,106,2.70 [1.32-5.53],0.006629084736243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,8060,98,0.80 [0.66-0.97],0.0238608298688365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,8952,98,1.59 [1.10-2.29],0.0139676728625455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,9199,105,1.40 [1.03-1.89],0.0320458176049902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,9201,105,0.81 [0.68-0.96],0.0184512385063237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,9126,103,0.73 [0.55-0.97],0.0318182990372129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,9238,106,0.68 [0.46-1.00],0.0495148375983233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,9168,106,0.84 [0.74-0.96],0.0097846126679438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,9172,103,0.67 [0.47-0.97],0.0340763400608033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,9121,106,1.56 [1.12-2.20],0.0095387116233937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,7791,95,1.48 [1.09-2.02],0.0125740381169834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,8029,98,0.69 [0.49-0.95],0.0234165007333494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,8029,98,0.84 [0.71-0.99],0.0370716908270003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,9055,105,0.53 [0.29-0.97],0.0385966037334543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,7888,96,2.58 [1.36-4.89],0.0038244209690589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,8052,99,1.70 [1.08-2.67],0.0226339655922019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,8987,101,1.51 [1.06-2.14],0.0221146466577688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,9180,104,0.75 [0.60-0.94],0.0103970577663528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,9015,102,0.40 [0.18-0.91],0.0293644703951446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,8037,96,1.43 [1.07-1.93],0.0173743511825129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,9168,106,1.27 [1.03-1.55],0.021688444919042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,9218,103,0.52 [0.27-0.99],0.044970088865353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,9188,103,0.79 [0.62-1.00],0.0498500084228975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,8987,101,0.63 [0.41-0.96],0.0330811308078408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,9226,106,1.99 [1.11-3.54],0.0200765381988212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,9254,103,1.38 [1.07-1.79],0.0128669294808306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,9229,104,2.15 [1.01-4.54],0.0459077913430871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,8070,98,0.71 [0.53-0.95],0.0204742800776456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,9213,105,0.73 [0.57-0.92],0.0086479547133038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,9168,106,0.81 [0.65-1.00],0.0462500903527267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,9099,106,2.43 [1.17-5.03],0.0168639848675284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",9268,104,0.76 [0.60-0.97],0.0252635478574687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,7791,95,2.29 [1.09-4.79],0.0288476158447921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,7791,95,1.30 [1.05-1.62],0.0173318062764632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,9023,101,0.67 [0.49-0.92],0.0126343437934843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,9105,106,1.81 [1.03-3.15],0.0377465928475716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,7921,97,2.90 [1.40-6.01],0.0042266426676574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,8029,98,0.82 [0.68-0.99],0.0435319024056702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",7921,97,0.75 [0.59-0.94],0.0136308142747737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,9184,104,0.78 [0.64-0.95],0.0152861333455453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,8037,96,1.46 [1.04-2.05],0.0271375157191354
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,9015,102,1.42 [1.10-1.83],0.0078495777680752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,7888,96,1.46 [1.05-2.05],0.026517337337876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",9153,102,0.71 [0.51-0.99],0.0458027440479543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,8987,101,1.23 [1.00-1.51],0.0454773425857781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,7935,94,1.25 [1.02-1.54],0.0302977004713149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",9199,105,0.78 [0.62-0.98],0.0326233260672086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,8968,102,0.56 [0.35-0.90],0.016973436145684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,9284,105,0.76 [0.60-0.95],0.016831204421778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,9268,104,1.61 [1.00-2.60],0.0487324102452034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,9232,106,0.76 [0.59-0.98],0.0336948730390753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,9146,105,1.81 [1.02-3.21],0.0436137791706373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,9268,104,1.55 [1.04-2.29],0.0296059414101735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,7799,96,1.48 [1.12-1.97],0.0062564511559585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,9286,104,0.84 [0.72-0.97],0.0217310301754881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,9023,101,1.53 [1.06-2.21],0.0235696171885947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,9053,105,0.72 [0.51-1.00],0.0488496964895473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,8037,96,1.70 [1.37-2.12],2.203325217712715e-06
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,9168,106,0.58 [0.38-0.88],0.0115338309907316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,9199,105,0.71 [0.52-0.98],0.039151257353102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,9129,106,0.73 [0.54-0.98],0.0387125139681728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,8949,102,0.60 [0.38-0.94],0.025109804584282
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,8029,98,1.40 [1.17-1.67],0.0002452464510362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,9168,106,1.62 [1.02-2.58],0.0415210745757173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,9199,105,0.36 [0.21-0.64],0.0004631990375371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,9268,104,0.32 [0.11-0.92],0.0338166316617825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,9015,102,0.85 [0.73-1.00],0.04629864194578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,9229,104,0.56 [0.34-0.93],0.0238220813222257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",8968,102,1.41 [1.05-1.89],0.0238858058413201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,8029,98,0.77 [0.61-0.97],0.023482212711511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,7917,97,0.59 [0.35-0.98],0.0405009216226844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,7799,96,1.25 [1.03-1.53],0.027520742302585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,8968,102,0.76 [0.59-0.98],0.0311499659694077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,9268,104,1.68 [1.32-2.13],2.042616862487232e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,9284,105,1.65 [1.07-2.54],0.023308692497091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,7799,96,1.39 [1.09-1.78],0.0074502484435476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,9249,103,1.50 [1.04-2.15],0.0292045709132388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,9238,106,0.58 [0.35-0.96],0.0334748220628434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,9238,106,0.86 [0.75-0.99],0.0307893749257355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,7935,94,0.74 [0.56-0.99],0.0402651141245071
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAX,Protein max,8968,102,0.80 [0.67-0.95],0.0127841368081777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,7852,92,1.84 [1.00-3.36],0.0486113583933737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,8064,99,0.48 [0.24-0.93],0.0287066019799922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,9199,105,0.85 [0.73-0.98],0.0232964881100576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",9168,106,0.74 [0.60-0.92],0.0063437483932003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,9168,106,0.84 [0.74-0.96],0.010975510615661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,8037,96,0.83 [0.70-1.00],0.0470268268570755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",7826,99,0.52 [0.33-0.82],0.0047206865039372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,9153,102,0.79 [0.64-0.99],0.03646950566127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,8016,96,1.47 [1.01-2.14],0.0461623190515858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",7826,99,0.49 [0.27-0.92],0.0254150716181874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,9229,104,1.89 [1.02-3.50],0.0426809497022637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,7826,99,1.65 [1.20-2.26],0.0019511661367184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,9207,106,0.60 [0.39-0.93],0.0225236059181547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,8008,96,0.73 [0.54-1.00],0.0469529619944745
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,9168,106,1.57 [1.11-2.20],0.0100449076131947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,9268,104,1.45 [1.10-1.92],0.0086589464461731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,9157,106,0.80 [0.66-0.96],0.0184416186433503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,9188,103,1.23 [1.06-1.44],0.0071821930667794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,9168,106,0.80 [0.64-1.00],0.0464234785400475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,9284,105,0.75 [0.57-0.99],0.0402883186979219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,8012,98,0.79 [0.62-0.99],0.043672663862978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,9199,105,0.63 [0.44-0.91],0.0127503765500437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,9153,102,0.63 [0.41-0.97],0.0346250277947985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,9129,106,1.26 [1.05-1.52],0.0151098283062262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,9188,103,1.68 [1.05-2.69],0.0304178840330882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,9300,104,1.72 [1.11-2.67],0.015241027382692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,8064,99,0.79 [0.65-0.97],0.0241609849246855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",7791,95,1.35 [1.06-1.72],0.0136373230507805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,7921,97,0.61 [0.39-0.95],0.0305837365963628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,9168,106,0.72 [0.54-0.96],0.0271055678719404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,9238,106,0.81 [0.66-0.98],0.0347544512443384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,9168,106,0.79 [0.64-0.98],0.0313004599175345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,9015,102,1.66 [1.01-2.73],0.0449034137402281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,9238,106,0.52 [0.36-0.73],0.0002280588876909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,9210,102,0.79 [0.66-0.95],0.0132790584063254
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,8052,99,0.73 [0.56-0.95],0.0199850079409301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,9129,106,0.63 [0.40-0.97],0.0362590256100668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,9202,104,1.32 [1.13-1.55],0.0006473278590751
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,8080,98,2.13 [1.32-3.44],0.0019386929274668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,8037,96,1.38 [1.07-1.78],0.0136058131162883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,8944,104,0.80 [0.65-1.00],0.0475588358472611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",9284,105,0.76 [0.59-0.96],0.0216355825321699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,9023,101,0.59 [0.40-0.87],0.007783681526676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,9188,103,0.78 [0.64-0.97],0.0226182293385357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,9134,105,1.76 [1.07-2.89],0.0264702089719441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,7784,96,0.66 [0.44-0.97],0.0341296564778328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,7852,92,1.33 [1.06-1.66],0.0131614306555231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,9220,106,0.80 [0.67-0.96],0.0163252675900295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,8029,98,1.76 [1.20-2.58],0.0041330267014589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,7927,97,1.41 [1.09-1.83],0.0091285682477727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,8968,102,0.65 [0.43-0.99],0.04709326225676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,9153,102,1.41 [1.06-1.86],0.0177831178475861
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,7849,98,1.25 [1.01-1.55],0.0444374648459843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,9268,104,1.63 [1.01-2.61],0.0436533463799472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,7849,98,1.58 [1.01-2.46],0.0442172010299429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,8959,105,1.67 [1.01-2.73],0.0436631632790826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,7826,99,1.57 [1.03-2.39],0.0339690437075839
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,7888,96,1.66 [1.08-2.56],0.0212772987609668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,9168,106,0.57 [0.40-0.80],0.0010286244149674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,7921,97,1.61 [1.06-2.43],0.0240581625455319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,9188,103,2.13 [1.11-4.07],0.0221614278259719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,9300,104,0.62 [0.41-0.94],0.024281921743409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,7932,96,2.87 [1.27-6.47],0.0111824584972627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,9169,104,0.78 [0.64-0.96],0.0204940082715153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,7907,97,0.47 [0.24-0.93],0.030446772868399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,7921,97,2.01 [1.25-3.26],0.0042773146947562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,8070,98,0.59 [0.43-0.81],0.0011705031287049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,8080,98,1.77 [1.04-3.00],0.0355298911146301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",8968,102,0.64 [0.43-0.94],0.0235570413133346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,9023,101,0.73 [0.57-0.92],0.0093887938146018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,9168,106,0.71 [0.52-0.96],0.0251538938889517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,9168,106,1.40 [1.15-1.70],0.0009229512921855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,9268,104,2.08 [1.32-3.28],0.0017036102845642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",9199,105,0.54 [0.33-0.89],0.0164494178535808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,8052,99,1.47 [1.08-2.01],0.0140762589427436
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,8987,101,1.74 [1.09-2.78],0.0194807232232405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,8064,99,1.88 [1.03-3.43],0.0402976717921537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,9288,103,0.70 [0.49-1.00],0.0474471453961876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,9172,103,1.17 [1.00-1.37],0.0456897638323828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",9153,102,0.60 [0.37-0.99],0.045635744790328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,9189,105,2.61 [1.24-5.46],0.0110623601175421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,7849,98,1.65 [1.12-2.44],0.0121174256886468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,8029,98,0.58 [0.34-0.99],0.0472232245927681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,9263,106,0.86 [0.76-0.98],0.0222504757890385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,8185,90,0.49 [0.25-0.95],0.0353995870120082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,9153,102,1.70 [1.08-2.68],0.0212414224375819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,9199,105,0.61 [0.39-0.95],0.0301925645586723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,8052,99,1.41 [1.05-1.88],0.0211628586693799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,9199,105,0.76 [0.59-0.98],0.0342410944769424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,7921,97,0.71 [0.51-1.00],0.049840540729062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,9129,106,1.35 [1.07-1.71],0.0111961818864943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,9215,102,0.71 [0.50-0.99],0.044781409322665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,9191,106,0.43 [0.23-0.80],0.0077698551850116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,7935,94,0.66 [0.50-0.86],0.0025888507813397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,7826,99,0.50 [0.31-0.82],0.0060491068558231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,7849,98,0.55 [0.33-0.94],0.0289554167348316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",9199,105,0.61 [0.41-0.91],0.015372450180651
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,9121,103,0.75 [0.57-0.99],0.0404960268686675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,7849,98,0.63 [0.42-0.96],0.0321370687062973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,9277,103,0.74 [0.55-1.00],0.0497580485502283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,9168,106,0.76 [0.61-0.95],0.0148044259880874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,9153,102,1.51 [1.14-2.01],0.004490127228326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,9263,106,0.70 [0.55-0.90],0.0043283752488595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,9096,106,1.84 [1.19-2.85],0.0063114393825335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,9259,104,1.37 [1.06-1.77],0.0145727733496666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,8744,99,1.69 [1.14-2.52],0.0092112968152501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",9103,106,1.89 [1.28-2.78],0.0012385612190609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,8968,102,0.54 [0.32-0.90],0.019324393900208
